Green Eric Mark (CIK 1336007) reported 16 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-14). Recent activity: Buy ECL (3,370 shares), Buy ECL (320 shares), Buy ECL (130 shares), Buy ECL (144 shares), Buy ECL (138 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | ECOLAB INC. (ECL) | Director | Buy | 3,370 | $932,064 |
| 2026-09-14 | ECOLAB INC. (ECL) | Director | Buy | 320 | $88,733 |
| 2026-07-02 | ECOLAB INC. (ECL) | Director | Buy | 130 | $0 |
| 2026-07-02 | ECOLAB INC. (ECL) | Director | Buy | 144 | $40,000 |
| 2026-04-02 | ECOLAB INC. (ECL) | Director | Buy | 138 | $0 |
| 2026-04-02 | ECOLAB INC. (ECL) | Director | Buy | 152 | $39,999 |
| 2026-02-19 | WEST PHARMACEUTICAL SERVICES INC (WST) | President, CEO and Board Chair | Buy | 4,419 | $0 |
| 2026-02-19 | WEST PHARMACEUTICAL SERVICES INC (WST) | President, CEO and Board Chair | Sell | 1,305 | $317,455 |
| 2026-02-19 | WEST PHARMACEUTICAL SERVICES INC (WST) | President, CEO and Board Chair | Buy | 1,319 | $0 |
| 2026-02-19 | WEST PHARMACEUTICAL SERVICES INC (WST) | President, CEO and Board Chair | Sell | 574 | $142,390 |
| 2026-01-05 | ECOLAB INC. (ECL) | Director | Buy | 128 | $0 |
| 2026-01-05 | ECOLAB INC. (ECL) | Director | Buy | 137 | $36,251 |
| 2025-10-02 | ECOLAB INC. (ECL) | Director | Buy | 123 | $0 |
| 2025-10-02 | ECOLAB INC. (ECL) | Director | Buy | 132 | $36,252 |
| 2025-07-02 | ECOLAB INC. (ECL) | Director | Buy | 126 | $0 |
| 2025-07-02 | ECOLAB INC. (ECL) | Director | Buy | 136 | $36,249 |
来源：SEC Form 4 申报文件 · 截至 2026-09-14